Robert Bradway vs Michel Vounatsos

Robert Bradway

CEO of Amgen

BIO: Mr. Robert A. Bradway, also known as Bob, has been the Chief Executive Officer of Amgen Inc. since May 23, 2012. Mr. Bradway is responsible for the Amgen's global commercial operations, manufacturing operations, information technology, global government affairs and worldwide compliance and business ethics organizations. He served as the President of Amgen Inc. from May 2010 to May 2012. He served as the Chief Operating Officer of Amgen from May 2010 to May 23, 2012. He served as the Chief Financial Officer and Executive Vice President at Amgen Inc. from April 10, 2007 to May 2010. Mr. Bradway joined Amgen in 2006 and served as its Vice President of Operations Strategy. He served as Managing Director in investment banking at Morgan Stanley, where he was responsible for the Morgan Stanley's banking department and corporate finance activities in Europe. He joined Morgan Stanley in New York as a health care industry investment banker in 1985 and moved to London in 1990, where he served as the Head of the Morgan Stanley's international health care investment banking activities. He has been the Chairman of Amgen Inc. since January 1, 2013. He has been an Independent Director of The Boeing Company since October 14, 2016. He has been a Director at Amgen Inc. since October 2011. He serves as a Trustee of University of Southern California. He served as an Independent Director of Norfolk Southern Corporation from July 2011 to May 11, 2017. He served as a Director of Micromet, Inc. from March 2, 2012 to March 7, 2012. He is chairman of the CEO Roundtable on Cancer, a non-profit organization comprised of executives founded to have solutions to cancer treatment and prevention. He holds a B.A in Biology from Amherst College and an MBA from Harvard University.

Michel Vounatsos

CEO of Biogen

BIO: Mr. Michel Vounatsos has been the Chief Executive Officer of Biogen Inc. since January 6, 2017. Mr. Vounatsos served as the Chief Commercial Officer and Executive Vice President of Biogen Inc. since April 18, 2016 until December 2016. He is a sophisticated global business leader who has a track record of commercial success and creativity. He joined Biogen after a 20 year career at Merck, where he various positions including served as president, Primary Care Business Line and Merck Customer Centricity. Prior to this role, he held leadership positions at Merck across Europe and in China. He has been Director of Biogen Inc. since January 6, 2017. Mr. Vounatsos attended the Universite Victor Segalen, Bordeaux II, in France, receiving his C.S.C.T. certificate in Medicine. He received his M.B.A. from the HEC School of Management in Paris.